By TheBloodApp Team·

Thalassemia and Blood Donation in India: Why 100,000 Patients Need You Every Month

Thalassemia and Blood Donation in India.

Thalassemia and Blood Donation in India.

There is a child somewhere in India right now — probably a child you will never meet — whose life depends entirely on whether a stranger somewhere chose to donate blood last month.

The child has thalassemia major. Their body cannot produce normal haemoglobin. Without regular blood transfusions every 3–4 weeks, their organs would suffer from chronic oxygen deprivation. Without transfusions, thalassemia major is fatal in early childhood.

With regular transfusions — good ones, properly typed and screened — these children grow up. They go to school. They live lives. The transfusions do not cure them, but they make survival possible.

India has more thalassemia patients than any other country in the world. And the blood they need, month after month, has to come from somewhere.


India's Thalassemia Burden: The Numbers

100,000 — the estimated number of people in India currently living with thalassemia major, the most severe form, which requires lifelong blood transfusions.

10,000 to 12,000 — the number of new children born with thalassemia major in India every year, according to the Indian Council of Medical Research (ICMR).

25% — India's share of the global thalassemia major burden. One in four thalassemia patients in the world lives in India.

1.5% — the proportion of India's general population that carries the thalassemia gene (thalassemia trait/minor). This makes thalassemia one of the most common genetic conditions in the country.

These numbers are not academic. They translate directly into blood bank demand. A single thalassemia major patient needs approximately 15–20 units of blood per year. Multiply that by 100,000 patients and you arrive at 1.5–2 million units of blood consumed annually by thalassemia patients alone — nearly 10–14% of India's entire annual blood collection.


What Is Thalassemia?

Thalassemia is an inherited blood disorder — passed from parent to child through genes — that affects the production of haemoglobin.

Haemoglobin is the protein in red blood cells that carries oxygen from the lungs to every organ in the body. In thalassemia, a mutation in the genes responsible for producing haemoglobin chains means the body either makes too little haemoglobin or makes an abnormal version that does not work properly.

The result is chronic anaemia — red blood cells that are fragile, misshapen, and short-lived, and an ongoing deficit of oxygen delivery throughout the body.

Types of Thalassemia

1. Thalassemia Minor (Trait): One copy of the mutated gene, inherited from one parent. Carriers of thalassemia minor typically have mild or no symptoms and live normal lives. They may have slightly lower haemoglobin than average. Critically, they can pass the gene on to their children — and if two carriers have children together, there is a 25% chance with each pregnancy that the child will have thalassemia major.

2. Thalassemia Major: Two copies of the mutated gene, inherited from both parents. This is the severe form. Children with thalassemia major begin showing symptoms in the first few months of life — extreme pallor, poor feeding, failure to thrive, and progressive anaemia. Without regular transfusions, survival beyond early childhood is unlikely.


Why Blood Transfusion Is Central to Treatment

There is currently no widely available cure for thalassemia major in India. A bone marrow (stem cell) transplant can offer a cure if a matched donor is found and the procedure is undertaken early — but this is available only to a minority of patients due to cost, donor availability, and logistical challenges.

For the vast majority of thalassemia major patients in India, lifelong blood transfusion is the treatment.

Every 3–4 weeks, patients need a transfusion of packed red blood cells (RBCs) to maintain their haemoglobin at a level that keeps them functional and prevents organ damage. If a transfusion is delayed or missed, patients experience severe fatigue, cardiac stress, and the progressive accumulation of iron (from all the transfused blood) that damages the liver, heart, and endocrine organs.

This is not a theoretical cycle. For families of thalassemia patients across India, it is an exhausting, lifelong monthly reality — finding blood, sourcing it, travelling to the blood bank, staying for the transfusion, managing the side effects.


The Quality of Blood Matters Too

Not just any blood will do.

Thalassemia patients who receive transfusions over many years progressively develop alloantibodies — immune responses to antigens on transfused red blood cells that are slightly different from their own. Once a patient develops alloantibodies, finding compatible blood becomes significantly harder.

A 2024 study published in Transfusion Clinique et Biologique highlighted that most blood centres in India lack the facilities for extended red cell antigen typing — the process needed to precisely match blood and prevent alloimmunization. This gap in the system means many thalassemia patients become harder to transfuse over time.

The solution is both technical (better blood bank infrastructure) and social: more voluntary donors whose blood is safer and more thoroughly screened than replacement donation.

Voluntary blood donation is associated with lower rates of transfusion-transmitted infections — a fact of enormous consequence for thalassemia patients who receive blood every month of their lives.


Who Are Thalassemia Patients in India?

Thalassemia is not confined to one region or community. It is found across India, though prevalence varies:

  • Punjab, Gujarat, Maharashtra, Rajasthan — particularly high rates of thalassemia trait
  • West Bengal — historically significant thalassemia burden, especially in certain communities
  • Tamil Nadu, Andhra Pradesh, Karnataka — also affected with regional variation

Certain communities — Sindhi, Punjabi, Gujarati, Bhanushali, and several others — have higher carrier rates due to historical patterns of marriage within communities.

The ICMR estimates that approximately 40 million people in India carry the thalassemia trait — making them potential transmitters without knowing it. Many carriers are unaware of their status because the trait itself causes minimal symptoms.


This depends on the type:

Thalassemia Major patients cannot donate blood. Their haemoglobin levels are too low to safely meet donation requirements, and they are permanently deferred.

Thalassemia Minor (Trait) carriers may be able to donate, depending on their haemoglobin levels on the day of screening. If their haemoglobin meets the minimum threshold of 12.5 g/dL, many blood banks will accept them. This is assessed case by case.

What thalassemia patients and their families can do — and do with remarkable dedication — is advocate for blood donation. Families managing thalassemia become among the most passionate ambassadors for voluntary donation precisely because they understand better than anyone what blood means to a life.


How Voluntary Blood Donation Directly Helps

Here is the direct chain:

  1. You register on TheBloodApp as a voluntary blood donor
  2. You donate blood every 3 months (men) or 4 months (women)
  3. Your donation is screened, separated into components, and stored
  4. A thalassemia child's treatment team requests packed RBCs that match their blood type
  5. Your donation is matched, crosschecked, and transfused
  6. A child who would otherwise be hospitalised with severe anaemia goes home to their family

That chain is real. It happens thousands of times a day in India. And it can only happen if you are in it.


What India Needs to Do Better

The challenges in thalassemia care in India are systemic:

  • Inadequate blood inventory — blood banks frequently struggle to maintain stocks of rare antigen-typed blood
  • Fragmented services — blood transfusion services vary enormously between states, and even between districts within the same state
  • Under-diagnosis — not all thalassemia carriers know they carry the gene; premarital thalassemia screening is recommended but not universally practiced
  • Limited bone marrow transplant access — the curative option remains out of reach for most families
  • Iron overload management — the chelation therapy required to remove iron buildup from years of transfusions is expensive and not always covered

Awareness, advocacy, and voluntary donation help with the first and most immediate challenge: keeping the blood supply adequate for the patients who need it right now, every month, without fail.


Be Part of the Answer

If you are an eligible blood donor — between 18 and 65, weighing at least 45 kg, and in reasonable health — you are already in a position to make a direct, measurable difference to a thalassemia patient's life.

You do not need to know them. You do not need to be a match for one specific person. You donate, you enter the supply chain, and the system does the rest.

Register on TheBloodApp today. Find blood donation camps and blood banks in Delhi, Mumbai, Bengaluru, Chennai, Hyderabad, Kolkata, Pune, and across India. For urgent requests or donation scheduling, call the number listed in the app.


Sources: ICMR — Thalassemia in India | Tata Medical Center Study — Transfusion Challenges, Thalassemia India (2024) | Transfusion Clinique et Biologique — Blood Transfusion Challenges in Indian Thalassemia Patients | ScienceDirect — Burden of Thalassemia in India | DATRI — World Thalassemia Day | India Blood Transfusion Market Study 2025 | The Week — Stem Cell Donation for Thalassemia

Background

Join India’s Most Reliable Blood Donation Network.

Be a part of the change — donate safely, stay connected, and help someone in need. Download the app today.

Available on

Download on the App StoreGet it on Google Play
App screenshot - blood camp
32 People Interested in blood camp
App screenshot - blood request dashboard